Recruiting Geographic Atrophy Studies in Los Angeles
About Geographic Atrophy Clinical Trials in Los Angeles
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 41 geographic atrophy clinical trials recruiting participants in Los Angeles, CA. These studies are seeking a combined 22,610 participants. Research is being sponsored by Genzyme, a Sanofi Company, Gilead Sciences, Merck Sharp & Dohme LLC and 29 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in Los Angeles — FAQ
Are there geographic atrophy clinical trials in Los Angeles?
Yes, there are 41 geographic atrophy clinical trials currently recruiting in Los Angeles, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Los Angeles?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.
Are clinical trials in Los Angeles free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 41 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated August 28, 2026 from ClinicalTrials.gov